Skip to main content
. Author manuscript; available in PMC: 2021 Jul 30.
Published in final edited form as: J Alzheimers Dis. 2021;79(3):1345–1367. doi: 10.3233/JAD-201292

Table 9.

Mediation Analyses for Association Between Patient Mindfulness, Resilience and Vulnerability Factors, and Cognition

MoCA Z score HVLT Recall HVLT delay Trailmaking B NSCT
Education a path (p) 0.023 (0.105) 0.023 (0.106) 0.024 (0.104) 0.025 (0.096) 0.014 (0.432) 0.014 (0.393)
b path (p) 0.471 (<0.001) 0.048 (0.014) 0.084 (0.017) 0.098 (0.027) −0.100 (0.028) 0.060 (0.045)
c path (p) 0.139 (<0.001) 0.013 (0.007) 0.038 (<0.001) 0.046 (<0.001) −0.036 (0.003) 0.023 (0.002)
c’ path (p) 0.128 (<0.001) 0.012 (0.013) 0.036 (<0.001) 0.043 (<0.001) −0.034 (0.004) 0.023 (0.003)
ab path 0.011 0.001 0.002 0.002 −0.001 0.001
(95% CI) (−0.0001; 0.030) (−0.000; 0.004) (0.0001; 0.006) (−0.0001; 0.007) (−0.006; 0.002) (−0.0001; 0.004)
ab/c 0.079 0.077 0.053 0.043 0.028 0.043
QPAR a path (p) 0.438 (<0.001) 0.437 (<0.001) 0.429 (<0.001) 0.426 (<0.001) 0.493 (<0.001) 0.457 (<0.001)
b path (p) 0.111 (<0.001) 0.017 (<0.001) 0.037 (<0.001) 0.047 (<0.001) −0.030 (<0.001) 0.026 (<0.001)
c path (p) 0.141 (<0.001) 0.013 (0.005) 0.039 (<0.001) 0.048 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.093 (0.004) 0.006 (0.187) 0.023 (0.005) 0.028 (0.008) −0.022 (0.062) 0.014 (0.068)
ab path 0.048 0.007 0.016 0.020 −0.015 0.012
(95% CI) (0.029; 0.076) (0.004; 0.011) (0.009; 0.022) (0.011; 0.032) (−0.024; −0.007) (0.006; 0.020)
ab/c 0.340 0.538 0.410 0.417 0.405 0.408
MIND diet a path (p) 0.021 (0.074) 0.021 (0.075) 0.021 (0.073) 0.024 (0.041) 0.039 (0.006) 0.033 (0.012)
b path (p) 0.463 (0.016) 0.061 (0.024) 0.148 (0.004) 0.235 (<0.001) −0.210 (0.002) 0.149 (<0.001)
c path (p) 0.144 (<0.001) 0.014 (0.005) 0.040 (<0.001) 0.048 (<0.001) −0.033 (0.012) 0.025 (0.003)
c’ path (p) 0.135 (<0.001) 0.013 (0.011) 0.037 (<0.001) 0.042 (<0.001) −0.025 (0.057) 0.020 (0.014)
ab path 0.010 0.001 0.003 0.006 −0.008 0.005
(95% CI) (0.0004; 0.026) (−0.000; 0.004) (0.0002; 0.009) (0.001; 0.013) (−0.018; −0.003) (0.001; 0.011)
ab/c 0.069 0.071 0.075 0.125 0.242 0.200
Social Engagement a path (p) 0.017 (0.001) 0.017 (0.001) 0.017 (0.002) 0.017 (0.002) 0.019 (0.002) 0.019 (<0.001)
b path (p) 1.573 (0.008) 0.182 (0.032) 0.554 (<0.001) 0.562 (0.006) −0.448 (0.021) 0.253 (0.058)
c path (p) 0.126 (0.003) 0.013 (0.032) 0.034 (0.003) 0.044 (0.002) −0.026 (0.064) 0.023 (0.014)
c’ path (p) 0.100 (0.018) 0.010 (0.109) 0.025 (0.029) 0.035 (0.017) −0.018 (0.216) 0.019 (0.056)
ab path 0.027 0.003 0.009 0.009 −0.009 0.005
(95% CI) (0.009; 0.065) (0.001; 0.007) (0.003; 0.019) (0.003; 0.021) (−0.019; −0.002) (0.001; 0.011)
ab/c 0.214 0.231 0.265 0.205 0.339 0.217
Age a path (p) −0.062 (0.187) −0.062 (0.185) 0.055 (0.253) −0.060 (0.216) −0.067 (0.242) −0.060 (0.249)
b path (p) −0.305 (<0.001) −0.043 (<0.001) −0.080 (<0.001) −0.118 (<0.001) 0.097 (<0.001) −0.080 (<0.001)
c path (p) 0.139 (<0.001) 0.013 (0.006) 0.039 (<0.001) 0.047 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.121 (<0.001) 0.010 (0.015) 0.035 (<0.001) 0.040 (<0.001) −0.030 (0.004) 0.020 (0.002)
ab path 0.019 0.003 0.004 0.007 −0.006 0.005
(95% CI) (−0.005; 0.051) (−0.001; 0.006) (−0.003; 0.012) (−0.002; 0.018) (−0.016; 0.003) (−0.002; 0.012)
ab/c 0.137 0.231 0.103 0.149 0.162 0.200
HADS-Depression a path (p) −0.126 (<0.001) −0.126 (<0.001) −0.131 (<0.001) −0.124 (<0.001) 0.123 (<0.001) −0.115 (<0.001)
b path (p) −0.087 (0.401) 0.004 (0.775) −0.061 (0.029) −0.055 (0.122) 0.037 (0.307) −0.026 (0.255)
c path (p) 0.138 (<0.001) 0.012 (0.008) 0.040 (<0.001) 0.048 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.127 (<0.001) 0.013 (0.010) 0.032 (<0.001) 0.041 (<0.001) −0.033 (0.010) .0022 (0.007)
ab path 0.011 −0.001 0.008 0.007 −0.005 0.003
(95% CI) (−0.014; 0.038) (−0.004; 0.004) (0.001; 0.016) (−0.003; 0.016) (−0.014; 0.004) (−0.003; 0.009)
ab/c 0.080 0.083 0.200 0.146 0.135 0.120
Fried Frailty a path (p) −0.039 (<0.001) −0.039 (<0.001) −0.037 (<0.001) −0.036 (<0.001) −0.038 (<0.001) −0.036 (<0.001)
b path (p) −2.189 (<0.001) −0.214 (<0.001) −0.543 (0.005) −0.737 (<0.001) 0.682(<0.001) −0.475 (<0.001)
c path (p) 0.140 (<0.001) 0.013 (0.006) 0.039 (<0.001) 0.047 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.055 (0.077) 0.005 (0.311) 0.019 (0.024) 0.021 (0.042) −0.011 (0.315) 0.008 (0.271)
ab path 0.085 0.008 0.020 0.026 −0.026 0.017
(95% CI) (0.054; 0.0121) (0.005; 0.013) (0.012; 0.030) (0.016; 0.038) (−0.040; −0.015) (0.010; 0.024)
ab/c 0.607 0.615 0.513 0.553 0.703 0.680
mCAIDE a path (p) −0.044 (0.003) −0.044 (0.003) −0.042 (0.005) −0.044 (0.004) −0.041 (0.022) −0.042 (0.011)
b path (p) −0.739 (<0.001) −0.091 (<0.001) −0.198 (<0.001) −0.243 (<0.001) 0.261 (<0.001) −0.209 (<0.001)
c path (p) 0.141 (<0.001) 0.013 (0.005) 0.039 (<0.001) 0.048 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.109 (<0.001) 0.009 (0.043) 0.031 (<0.001) 0.037 (<0.001) −0.027 (0.015) 0.016 (0.019)
ab path 0.032 0.004 0.008 0.011 −0.011 0.009
(95% CI) (0.011; 0.059) (0.002; 0.008) (0.003; 0.017) (0.004; 0.020) (−0.021; −0.002) (0.003; 0.017)
ab/c 0.227 0.308 0.250 0.229 0.297 0.36
Charlson Comorbidities a path (p) −0.003 (0.739) −0.003 (0.734) −0.004 (0.633) −0.004 (0.684) 0.003 (0.811) −0.000 (0.988)
b path (p) −0.892 (<0.001) −0.102 (0.002) −0.315 (<0.001) −0.386 (<0.001) 0.321 (<0.001) −0.203 (<0.001)
c path (p) 0.141 (<0.001) 0.013 (0.005) 0.039 (<0.001) 0.048 (<0.001) −0.037 (0.002) 0.025 (0.001)
c’ path (p) 0.139 (<0.001) 0.013 (0.005) 0.038 (<0.001) 0.047 (<0.001) −0.038 (<0.001) 0.025 (<0.001)
ab path 0.003 0.0003 0.001 0.001 0.001 0.000
(95% CI) (−0.011; 0.019) (−0.001; 0.002) (−0.004; 0.007) (−0.004; 0.008) (−0.005; 0.006) (−0.003; 0.004)
ab/c 0.021 0.023 0.026 0.021 0.027

Bold signifies significant p-value after controlling for multiple comparisons. MoCA, Montreal Cognitive Impairment; HVLT, Hopkins Verbal Learning Task; NSCT, Number Symbol Coding Task; QPAR, Quick Physical Activity Rating; MIND, Mediterranean-DASH Intervention for Neurodegenerative Delay; HADS, Hospital Anxiety and Depression Scale; mCAIDE, modified Cardiovascular Risk Factors, Aging, and Dementia.